Form 4: Eli Lilly Executive Gifts Shares Under 10b5-1 Plan

Eli Lilly's EVP & President of Manufacturing Operations, Edgardo Hernandez, reported gifting 17 shares of common stock.

Summary

• Edgardo Hernandez, Executive Vice President and President of Manufacturing Operations at Eli Lilly & Co., reported a disposition of company common stock.
• The transaction involved gifting 17 shares of common stock on September 5, 2025.
• The shares were disposed of at a price of $0 per share, consistent with a gift.
• Following the transaction, Hernandez directly owns 39,731.435 shares of common stock and indirectly owns 872.3 shares through a 401(k) plan.
• The transaction was made pursuant to a Rule 10b5-1(c) plan, indicating it was pre-arranged.

Sentiment

Score: 6

Explanation: The disposition of shares was a gift, not a sale for cash, and was executed under a pre-arranged 10b5-1 plan. This generally indicates a planned personal financial move rather than a reaction to company-specific news. The number of shares is also relatively small compared to the executive's total holdings, leading to a neutral to slightly positive sentiment.

Positives

• The transaction was a gift, not a sale for cash, which is generally viewed as a neutral to slightly positive signal regarding the executive's long-term commitment to the company.
• The disposition was executed under a pre-arranged Rule 10b5-1(c) plan, indicating a structured and transparent approach to managing personal holdings rather than a reaction to new, non-public information.

Negatives

• A minor reduction in direct beneficial ownership by an executive, although due to a gift rather than a sale.

Risks

• NA

Future Outlook

The transaction on September 5, 2025, was made pursuant to a Rule 10b5-1(c) plan, indicating a pre-scheduled disposition of shares as part of the executive's personal financial planning.

Management Comments

• NA

Industry Context

This is a routine insider transaction for an executive, common across all industries for personal financial planning and estate management. It does not reflect specific industry trends or competitive dynamics within the pharmaceutical sector.

Comparison to Industry Standards

• NA

Management Changes

Corporate Governance

Legal Proceedings

• NA

Related Party Transactions

• NA

Stakeholder Impact

• Shareholders: The impact on shareholders is negligible due to the small number of shares (17) involved in the gift, which does not materially affect the company's outstanding share count or market valuation.
• Employees: No direct impact on employees is indicated by this personal transaction.

Next Steps

• NA

Key Dates

Recommendation

The filing details a minor, pre-planned gift of shares by an executive, which is a routine personal financial management event. It does not provide any new material information about the company's financial performance, strategic direction, or operational health that would warrant a change in investment recommendation. The transaction is too small to have a significant impact on the stock price or investor sentiment for a company of Eli Lilly's size.

Keywords

Eli Lilly, LLY, Edgardo Hernandez, Insider Transaction, Form 4, Stock Gift, Executive Stock Ownership, Pharmaceuticals, 10b5-1 Plan